Creoptix becomes part of Malvern Panalytical
Elisabeth Schoch2022-01-18T08:37:09+00:00Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix
(Source: Press Release)
Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix
(Source: Press Release)
The Start Angels Network has been actively investing in Swiss startups for more than two decades. Last year, despite the corona crisis, the club managed to invest CHF 19.7 million in 14 financing rounds for 4 new companies and 10 portfolio firms. One SAN portfolio company achieved a very valuable exit.
Our last StartAngels event took place as a hybrid event at SIX ConventionPoint. Once again, exciting start-ups have presented themselves:
Clickahoy: www.clickahoy.com
CompPair: www.comppair.ch
LEDCity: www.ledcity.ch
MICTIC: www.mictic.com
ETH Zurich has continuously expanded its spin-off commitment. 500 such spin-offs have been created here since 1996. Last year alone, 30 new companies were founded by researchers from the Federal Institute of Technology – more than ever before.